Company Filing History:
Years Active: 2021
Title: Akira Ainai: Innovator in Antibody Technology
Introduction
Akira Ainai is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. Her innovative work has the potential to impact medical treatments and therapeutic applications.
Latest Patents
Ainai holds a patent for a polymeric IgA-type recombinant antibody and its uses. This patent includes a polymeric IgA-type recombinant antibody, a medicine containing this antibody as an active ingredient, and a method for producing the antibody. The production method involves coexpressing an IgA-type antibody heavy-chain protein, an antibody light-chain protein, an antibody J-chain protein, and a secretory component protein within a single cell. Additionally, the patent outlines a method for enhancing the antigen-binding activity or neutralizing activity of the antibody by converting it into a polymeric IgA-type.
Career Highlights
Throughout her career, Ainai has worked with notable organizations, including Nippi Corporation and the National Institute of Infectious Diseases in Japan. Her experience in these institutions has allowed her to refine her expertise in antibody research and development.
Collaborations
Ainai has collaborated with esteemed colleagues such as Shinji Saito and Tadaki Suzuki. These partnerships have contributed to her innovative research and advancements in antibody technology.
Conclusion
Akira Ainai is a trailblazer in the field of recombinant antibodies, with her patent showcasing her innovative approach to medical science. Her work continues to pave the way for future advancements in therapeutic applications.